SomnoMed Limited
ASX:SOM.AX
0.44 (AUD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 91.651 | 83.616 | 72.58 | 62.706 | 57.296 | 58.892 | 52.394 | 49.327 | 44.084 | 34.438 | 30.275 | 18.489 | 15.329 | 12.513 | 10.992 | 7.995 | 3.658 | 2.273 | 1.786 | 0.377 | 0.028 |
| Cost of Revenue
| 42.295 | 37.847 | 33.428 | 28.802 | 27.282 | 24.32 | 20.538 | 20.517 | 18.741 | 14.946 | 13.465 | 6.221 | 4.889 | 4.159 | 4.63 | 3.679 | 1.701 | 1.271 | 0.985 | 0.349 | 0.051 |
| Gross Profit
| 49.356 | 45.769 | 39.152 | 33.904 | 30.014 | 34.572 | 31.856 | 28.81 | 25.343 | 19.492 | 16.81 | 12.268 | 10.44 | 8.353 | 6.362 | 4.317 | 1.957 | 1.002 | 0.801 | 0.028 | -0.023 |
| Gross Profit Ratio
| 0.539 | 0.547 | 0.539 | 0.541 | 0.524 | 0.587 | 0.608 | 0.584 | 0.575 | 0.566 | 0.555 | 0.664 | 0.681 | 0.668 | 0.579 | 0.54 | 0.535 | 0.441 | 0.448 | 0.074 | -0.827 |
| Reseach & Development Expenses
| 0 | 0.706 | 0.978 | 0.958 | 0.904 | 1.06 | 0.949 | 0.954 | 0.881 | 0.743 | 0.631 | 0.579 | 2.356 | 2.303 | 1.769 | 1.786 | 1.405 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 13.114 | 12.622 | 11.178 | 10.048 | 11.196 | 9.381 | 12.678 | 8.411 | 6.414 | 5.475 | 3.468 | 2.925 | 1.912 | 1.874 | 1.583 | 1.516 | 1.951 | 3.53 | 1.994 | 0.205 |
| Selling & Marketing Expenses
| 0 | 24.491 | 19.74 | 15.584 | 15.437 | 14.967 | 13.789 | 13.698 | 11.943 | 9.496 | 7.637 | 5.543 | 4.259 | 3.396 | 2.455 | 2.598 | 1.485 | 1.265 | 1.683 | 0 | 0.255 |
| SG&A
| 57.672 | 49.136 | 42.305 | 33.598 | 30.051 | 32.205 | 28.673 | 31.312 | 24.205 | 18.822 | 15.885 | 11.56 | 7.184 | 5.308 | 4.329 | 4.181 | 3.001 | 3.216 | 5.213 | 1.994 | 0.205 |
| Other Expenses
| 0 | -0.348 | 1.016 | 0.586 | 2.148 | 0.001 | -0.083 | -0.093 | 0.378 | 0.863 | -0.055 | 0.047 | 0.055 | 0.091 | -0.022 | -0.053 | -0.1 | 0.149 | 0.254 | -0.007 | 0.001 |
| Operating Expenses
| 57.672 | 49.842 | 43.284 | 34.556 | 30.955 | 33.788 | 30.073 | 32.678 | 24.898 | 18.923 | 16.593 | 12.046 | 9.981 | 7.832 | 6.254 | 6.286 | 4.83 | 4.41 | 5.355 | 3.66 | 0.54 |
| Operating Income
| -8.316 | -4.073 | -4.131 | -0.651 | -0.941 | 0.918 | 2.005 | -3.735 | 0.118 | 0.041 | 0.315 | 0.205 | 0.459 | 0.522 | 0.018 | -1.969 | -2.873 | -3.755 | -4.555 | -3.632 | -0.564 |
| Operating Income Ratio
| -0.091 | -0.049 | -0.057 | -0.01 | -0.016 | 0.016 | 0.038 | -0.076 | 0.003 | 0.001 | 0.01 | 0.011 | 0.03 | 0.042 | 0.002 | -0.246 | -0.785 | -1.652 | -2.55 | -9.632 | -20.025 |
| Total Other Income Expenses Net
| -2.955 | -2.973 | 0.636 | -0.083 | 1.688 | -0.311 | -0.17 | -0.029 | 0.373 | 0.657 | -0.084 | 0.11 | 0.13 | 0.146 | 0.007 | -0.062 | -0.143 | 0.149 | 0.254 | -0.007 | 0.001 |
| Income Before Tax
| -11.271 | -7.045 | -3.496 | -0.734 | 0.747 | 0.607 | 1.835 | -3.764 | 0.491 | 0.698 | 0.23 | 0.315 | 0.589 | 0.668 | 0.114 | -1.803 | -2.731 | -3.274 | -4.188 | -3.267 | -0.557 |
| Income Before Tax Ratio
| -0.123 | -0.084 | -0.048 | -0.012 | 0.013 | 0.01 | 0.035 | -0.076 | 0.011 | 0.02 | 0.008 | 0.017 | 0.038 | 0.053 | 0.01 | -0.225 | -0.747 | -1.44 | -2.345 | -8.662 | -19.789 |
| Income Tax Expense
| 0.971 | 0.822 | 0.931 | 0.349 | 1.185 | 0.647 | 1.61 | 0.399 | 0.424 | 0.164 | 0.016 | 0.39 | -0.111 | -0.072 | -0.672 | 0.016 | -0.133 | 0.165 | 0.284 | -3.267 | -0.557 |
| Net Income
| -12.242 | -7.999 | -4.437 | -1.193 | -1.119 | -0.039 | 2.317 | -3.344 | 0.165 | 0.597 | 0.406 | 0.589 | 0.525 | 0.74 | 0.786 | -1.819 | -2.731 | -3.274 | -4.188 | -3.267 | 0 |
| Net Income Ratio
| -0.134 | -0.096 | -0.061 | -0.019 | -0.02 | -0.001 | 0.044 | -0.068 | 0.004 | 0.017 | 0.013 | 0.032 | 0.034 | 0.059 | 0.072 | -0.227 | -0.747 | -1.44 | -2.345 | -8.662 | 0 |
| EPS
| -0.1 | -0.097 | -0.054 | -0.015 | -0.017 | -0.001 | 0.042 | -0.062 | 0.003 | 0.013 | 0.01 | 0.014 | 0.011 | 0.015 | 0.017 | -0.04 | -0.071 | -0.16 | -0.31 | -0.25 | -0.18 |
| EPS Diluted
| -0.1 | -0.097 | -0.054 | -0.015 | -0.017 | -0.001 | 0.042 | -0.062 | 0.003 | 0.012 | 0.009 | 0.014 | 0.011 | 0.015 | 0.017 | -0.04 | -0.071 | -0.16 | -0.31 | -0.25 | -0.18 |
| EBITDA
| -2.541 | 1.044 | -0.195 | 3.188 | 2.144 | 2.845 | 3.667 | -2.567 | 1.039 | 0.573 | 0.849 | 0.708 | 0.9 | 0.742 | 0.264 | -1.65 | -2.298 | -2.911 | -4.016 | -3.184 | -0.563 |
| EBITDA Ratio
| -0.028 | 0.012 | -0.003 | 0.051 | 0.037 | 0.048 | 0.07 | -0.052 | 0.024 | 0.017 | 0.028 | 0.038 | 0.059 | 0.059 | 0.024 | -0.206 | -0.628 | -1.281 | -2.249 | -8.442 | -19.993 |